Published in Proc Soc Exp Biol Med on July 01, 1969
Measurement of fibrinopeptide A in human blood. J Clin Invest (1974) 2.01
Secondary haemorrhagic disease of the newborn. Arch Dis Child (1970) 1.71
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Coagulation studies in severe birth asphyxia. Arch Dis Child (1971) 1.40
Disseminated intravascular coagulation complicating infectious mononucleosis. Br Med J (1971) 1.33
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest (1983) 1.31
Coagulation studies in preterm infants with respiratory distress and intracranial haemorrhage. Arch Dis Child (1972) 1.26
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function. Ann Surg (1977) 1.24
The pathogenesis of leptospirosis I. Hemorrhages in experimental leptospirosis in guinea pigs. Can J Comp Med (1977) 1.21
Effects of progestogen oral contraception with norethisterone on blood clotting and platelets. Br Med J (1972) 1.18
Haemostatic failure in babies with rhesus isoimmunization. Arch Dis Child (1971) 1.16
Boerhaave syndrome: report of a case treated non-operatively. Ann Surg (1975) 1.10
Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure. Gut (1974) 1.06
The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. J Clin Invest (1976) 1.05
The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. Gut (1975) 1.04
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. J Clin Invest (1982) 1.01
Genus-specific leptospiral antigen and its possible use in laboratory diagnosis. J Clin Pathol (1973) 1.00
Factor VII levels as a guide to prognosis in fulminant hepatic failure. Gut (1976) 0.98
A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut (1974) 0.98
Inhibition of gastric plasmin activity by epsilon-aminocaproic acid. Ann R Coll Surg Engl (1973) 0.97
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J (1976) 0.96
Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol (1981) 0.95
Detection of fibrinogen-fibrin degradation products by counterelectrophoresis. J Clin Pathol (1972) 0.94
Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg (1977) 0.94
Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest (1979) 0.93
Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis. Br Med J (1974) 0.92
Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut (1975) 0.91
Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest (1987) 0.87
Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease. Arch Dis Child (1972) 0.86
Detection of fibrinogen antigens with two latex techniques applied to urine concentrates. J Clin Pathol (1973) 0.84
Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. Br Med J (1975) 0.83
Fibrin degradation products in rheumatoid arthritis. Ann Rheum Dis (1972) 0.82
A comparison of the TRCII and latex-particle tests for the titration of FR-antigen. J Clin Pathol (1972) 0.79
Experience with disseminated intravascular coagulation in a children's hospital. Can Med Assoc J (1972) 0.78
Development and treatment of post-traumatic pulmonary platelet trapping. Ann Surg (1975) 0.78
Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. J Clin Invest (1972) 0.78
Intravascular coagulation. Postgrad Med J (1972) 0.78
Platelet defect of infectious mononucleosis. Br Med J (1971) 0.77
Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis. Proc Natl Acad Sci U S A (1983) 0.77
Subendocardial infarction and thrombocytopenia. Postgrad Med J (1979) 0.77
Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens. J Clin Invest (1974) 0.76
Adrenergic, coagulation, and fibrinolytic responses to heat. Br Med J (1974) 0.75
Coagulation and fibrinolysis after injury. J Clin Pathol Suppl (R Coll Pathol) (1970) 0.75
Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis. J Natl Med Assoc (1985) 0.75
Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity. Ann Rheum Dis (1984) 0.75
Letter: prognostic significance of serum levels of fibrin/fibrinogen degradation products and of myocardial enzymes in acute myocardial infarction. J Clin Pathol (1976) 0.75
Standardization of diagnostic materials. 3. Laboratory reagents and coagulation assay procedures. Bull World Health Organ (1973) 0.75
Discrepancies between immunological and caseinolytic plasma plasminogen assays in health and hyperfibrinolytic states. J Clin Pathol (1974) 0.75
A structured approach to the management of purpura fulminans. J Natl Med Assoc (1983) 0.75
The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products. J Clin Pathol (1973) 0.75
Twenty-four hour left ventricular bypass with a centrifugal blood pump. Ann Surg (1975) 0.75
The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays. J Clin Pathol (1974) 0.75
Factor VIII levels during the course of acute hepatitis in a haemophiliac. J Clin Pathol (1975) 0.75
Serum lipids, typing, fibrinolysis, and smoking. Br Med J (1970) 0.75
Laboratory investigations of the DIC syndrome. Ir J Med Sci (1973) 0.75
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49
Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood (1966) 6.49
The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol (1967) 3.67
Comparison of the tine and Mantoux tuberculin tests. Report of the Tuberculin Subcommittee of the Researched Committee of the British Thoracic Association. Br Med J (1978) 3.62
Circumstances of death from asthma. Br Med J (Clin Res Ed) (1984) 2.71
Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, etiologic agent of equine ehrlichiosis. Am J Vet Res (1975) 2.67
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
A mew method for detection of red blood cell antibodies. Transfusion (1970) 1.81
GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol Cell (1998) 1.68
Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates. Br J Haematol (1971) 1.64
Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh (1969) 1.59
Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease. Br Med J (1960) 1.57
Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. Blood (1983) 1.42
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol (1990) 1.31
Color vision deficits during laser lithotripsy using safety goggles for coumarin green or alexandrite but not with holmium:YAG laser safety goggles. J Urol (1998) 1.30
Equine piroplasmosis: production of antigens for the complement-fixation test. Am J Vet Res (1969) 1.28
Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol (1982) 1.28
Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol (1975) 1.26
Experimentally induced sarcocystis infection in calves: pathology. Am J Vet Res (1975) 1.25
Equine piroplasmosis: complement-fixation titers of horses infected with Babesia caballi. Am J Vet Res (1969) 1.25
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features. Leukemia (2012) 1.24
Experimental infections with African Trypanosomes. VI. Glomerulonephritis involving the alternate pathway of complement activation. Am J Trop Med Hyg (1974) 1.23
New effectors of human hemoglobin: structure and function. Biochemistry (1990) 1.19
The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies. Transfusion (1980) 1.16
Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res (1987) 1.16
Neutrophil-specific antigens: immunology and clinical significance. Semin Hematol (1974) 1.13
Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol (1995) 1.11
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine (1988) 1.09
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia (2011) 1.07
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells. Leukemia (2012) 1.05
Comparison of multiple puncture liquid tuberculin test with Mantoux test. Lancet (1981) 1.05
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect Immun (1995) 1.03
Protracted survival after homotransplantation of the lung and simultaneous contralateral pulmonary artery ligation. J Thorac Cardiovasc Surg (1969) 1.02
Hematologic, biochemical, and parasitologic parameters of the night monkey (Aortus trivirgatus). Lab Anim Sci (1971) 1.01
Intravenous infusion of salbutamol in the treatment of asthma. Br J Clin Pharmacol (1975) 1.00
Preparation of the major plasma fractions by solid-phase polyelectrolytes. J Lab Clin Med (1978) 1.00
NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest (1971) 0.99
Defibrination syndrome or? Blood (1973) 0.99
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
Experimental infections with African trypanosomes. V. Preliminary parasitological, clinical, hematological, serological, and pathological observations in rhesus monkeys infected with Trypanosoma rhodesiense. Am J Trop Med Hyg (1973) 0.98
Experimental infection with Schistosoma japonicum in chimpanzees. Am J Trop Med Hyg (1971) 0.98
Phosphoinositide 3-kinase facilitates antigen-stimulated Ca(2+) influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca(2+) entry mechanism. J Biol Chem (2001) 0.97
Monomeric class I molecules mediate TCR/CD3 epsilon/CD8 interaction on the surface of T cells. J Immunol (2001) 0.97
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage (2010) 0.97
Development of Sarcocystis fusiformis in calves infected with sporocysts from dogs. J Parasitol (1973) 0.97
Lies, damned lies, and waiting lists. BMJ (1991) 0.97
Purification of antihemophilic factor (AHF) for clinical and experimental use. Thromb Diath Haemorrh Suppl (1967) 0.96
Chronic autoimmune neutropenia due to anti-NA2 antibody. N Engl J Med (1975) 0.96
Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology. Vet Pathol (1984) 0.96
Visceral leishmaniasis in the German shepherd dog. II. Pathology. Vet Pathol (1984) 0.95
[Clinical investigation of intermediate- and high-purity antihaemophilic factor (factor VIII) concentrates]. Br J Haematol (1971) 0.95
Temperature gradient dissociation of red cell antigen-antibody complexes in the polybrene technique. Br J Haematol (1971) 0.95
Autoimmune neutropenia of infancy. J Pediatr (1986) 0.93
Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. AJNR Am J Neuroradiol (2011) 0.93
Molecular weights of antihaemophilic factor and von Willebrand factor proteins in human plasma. Nature (1976) 0.92
The metabolic effects of inhaled salbutamol. Br J Clin Pharmacol (1978) 0.92
Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. JAMA (1972) 0.92
Fluorescent prey traps in carnivorous plants. Plant Biol (Stuttg) (2013) 0.91
Ability of thrombocytes to acquire HLA specificity from plasma. Blood (1982) 0.91
An isologous antigen-antibody reaction with human neutrophiles, related to neonatal neutropenia. J Clin Invest (1966) 0.90
Experimental infection with Plasmodium falciparum in Aotus monkeys. I. Parasitologic, hematologic, and serum biochemical determinations. Am J Trop Med Hyg (1972) 0.90
Isoimmune neonatal neutropenia. J Pediatr (1972) 0.89
The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med (2009) 0.89
Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients. Blood (1973) 0.89
Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance. Am J Trop Med Hyg (1991) 0.89
Spontaneous macrophage-erythrocyte rosette formation. A species-specific phenomenon. Immunology (1974) 0.89
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. Proc Natl Acad Sci U S A (1988) 0.89
Defibrination in normal and abnormal parturition. Br J Haematol (1970) 0.89
Seroprevalence of Japanese encephalitis virus and risk factors associated with seropositivity in pigs in four mountain districts in Nepal. Zoonoses Public Health (2012) 0.88
Neutrophil kinetics in Felty's syndrome. Am J Med (1980) 0.88
The absorption and elimination of ICI 74,917 in man. Br J Clin Pharmacol (1977) 0.88
Intranuclear coccidiosis in tortoises: nine cases. Vet Pathol (2006) 0.88
New methods for the preparation of biospecific adsorbents and immobilized enzymes utilizing trichloro-s-triazine. Anal Biochem (1978) 0.87
Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens. Hybridoma (1996) 0.87
The production of congenital malformations using tissue antisera. VII. Yolk-sac antiserum. Teratology (1971) 0.87
The fate of the renal transplant with delayed function. Surg Gynecol Obstet (1973) 0.87
Cultivation of Plasmodium falciparum parasites in a serum-free medium. Am J Trop Med Hyg (1993) 0.87
Trypanosoma rhodesiense: evaluation of the antitrypanosomal action of 2,5-bis(4-guanylphenyl)furan dihydrochloride. Exp Parasitol (1982) 0.87
Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B. Infect Immun (1993) 0.86
Isolation of fibrinogen-fibrin related antigen from human plasma by immuno-affinity chromatography: its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer. Br J Haematol (1980) 0.86
Methyldopa: physicochemical characterization of the erythrocyte autoantibody. Blood (1973) 0.86
Polybrene-induced red blood cell aggregation in vitro. Morphological aspects. Transfusion (1972) 0.85
Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels. Thromb Haemost (1977) 0.85
Modifying effects of exercise on clinical course and biochemical response of the myocardium in influenza and tularemia in mice. Infect Immun (1984) 0.85
Clinical significance of leukocyte iso- and auto-antibodies. Semin Hematol (1966) 0.84
Serologic profile in autoimmune hemolytic disease: pathophysiologic and clinical interpretations. Semin Hematol (1976) 0.84
Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol. Vox Sang (1979) 0.83
Recent advances in experimental thrombogenesis. Fed Proc (1965) 0.83